{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T19:32:37Z","timestamp":1776454357403,"version":"3.51.2"},"reference-count":41,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2014,9,15]],"date-time":"2014-09-15T00:00:00Z","timestamp":1410739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Michael Smith Foundation"},{"name":"Alberta Heritage Foundation"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabet. Med."],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>To determine the prescribing of and adherence to oral hypoglycaemic agents, insulin, angiotensin\u2010converting enzyme inhibitors, angiotensin receptor blockers and statin therapy among South\u2010Asian, Chinese and white people with newly diagnosed diabetes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The present study was a population\u2010based cohort study using administrative and pharmacy databases to include all South\u2010Asian, Chinese and white people aged \u2265 35 years with diabetes living in British Columbia, Canada (1997\u20132006). Adherence to each class of medication was measured using proportion of days covered over 1 year with optimum adherence defined as \u2265 80%.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study population included 9529 South\u2010Asian, 14 084 Chinese and 143 630 white people with diabetes. The proportion of people who were prescribed angiotensin\u2010converting enzyme inhibitors, angiotensin receptor blockers, statin or oral hypoglycaemic agents was \u2264 50% for all groups. South\u2010Asian and Chinese people had significantly lower adherence for all medications than white people, with the lowest adherence to angiotensin\u2010converting enzyme inhibitor treatment (South\u2010Asian people: adjusted odds ratio 0.37, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0.34\u20130.39; <jats:italic>P<\/jats:italic>&lt;0.0001; Chinese people: adjusted odds ratio 0.50, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0.47\u20130.54; <jats:italic>P<\/jats:italic>&lt;0.0001) and statin therapy (South\u2010Asian people: adjusted odds ratio 0.47, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0.41\u00a0\u2013\u00a00.53, <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.0001; Chinese people: adjusted odds ratio 0.72, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 0.67\u00a0\u2013\u00a00.77; <jats:italic>P<\/jats:italic>&lt;0.0001) compared with white people.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Adherence to evidence\u2010based pharmacotherapy was substantially worse among the South\u2010Asian and Chinese populations. Care providers need to be alerted to the high levels of non\u2010adherence in these groups and the underlying causes need to be investigated.<\/jats:p><\/jats:sec>","DOI":"10.1111\/dme.12559","type":"journal-article","created":{"date-parts":[[2014,8,11]],"date-time":"2014-08-11T10:55:38Z","timestamp":1407754538000},"page":"1586-1593","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Prescribing patterns and adherence to medication among South\u2010Asian, Chinese and white people with Type 2 diabetes mellitus: a population\u2010based cohort study"],"prefix":"10.1111","volume":"31","author":[{"given":"E.","family":"Chong","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences University of British Columbia Vancouver BC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Health Evaluation and Outcome Sciences Vancouver BC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. M.","family":"King\u2010Shier","sequence":"additional","affiliation":[{"name":"Faculty of Nursing Department of Community Health Sciences University of Calgary AB"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Quan","sequence":"additional","affiliation":[{"name":"Division of Medicine, Community Health and Cardiac Sciences University of Calgary AB"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. M.","family":"Rabi","sequence":"additional","affiliation":[{"name":"Division of Medicine, Community Health and Cardiac Sciences University of Calgary AB"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. A.","family":"Khan","sequence":"additional","affiliation":[{"name":"Center for Health Evaluation and Outcome Sciences Vancouver BC"},{"name":"Faculty of Medicine University of British Columbia Vancouver BC Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,9,15]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"407","article-title":"Impact of diabetes on coronary artery disease in women and men: a meta\u2010analysis in Ontario, Canada 1996\/97","volume":"27","author":"Lee WL","year":"2004","journal-title":"Diabetes Care"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.8.1879"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.2.355"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.7.1138"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0393-2"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2008.155796"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.19.2070"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011161"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16895-5"},{"key":"e_1_2_8_11_1","first-page":"39","article-title":"Update on the Canadian Diabetes Association 2008 clinical practice guidelines","volume":"55","author":"Bhattacharyya OK","year":"2009","journal-title":"Can Fam Physician"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083292"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-007-0267-4"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1940"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38803.528113.55"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jada.2009.07.003"},{"key":"e_1_2_8_17_1","first-page":"10","article-title":"Ethnocultural affiliation, gender, and cardiovascular disease risk management","volume":"15","author":"King KM","year":"2005","journal-title":"Can J Cardiovasc Nurs"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2007.03.005"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2010.03.007"},{"key":"e_1_2_8_20_1","unstructured":"Nam Pehchan News Summer 1998. Bradford: Computer Services Bradford Council (Dept 13)."},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000204010.81331.a9"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/21.4.401"},{"key":"e_1_2_8_23_1","first-page":"46","article-title":"The potential to identify South Asians using a computerized algorithm to classify names","volume":"97","author":"Harding S","year":"1999","journal-title":"Popul Trends"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1230"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H018"},{"key":"e_1_2_8_26_1","first-page":"449","article-title":"Estimating medication persistency using administrative claims data","volume":"11","author":"Sikka R","year":"2005","journal-title":"Am J Manag Care"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.09.021"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e31817924d2"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903126833"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.07.033"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2010.08.002"},{"key":"e_1_2_8_32_1","first-page":"e87","article-title":"Ethnic differences in the use of prescription drugs: a cross\u2010sectional analysis of linked administrative data","volume":"5","author":"Morgan S","year":"2011","journal-title":"Open Med"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-11-56"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2011.08.111"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010382911"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2648.2007.04537.x"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062775"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1177\/1043659607305194"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1993.tb00038.x"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1891\/088971807782427967"},{"key":"e_1_2_8_41_1","unstructured":"Health Canada safety information for rosuvastatin (Crestor). Available at:http:\/\/www.healthycanadians.gc.ca\/recall-alert-rappel-avis\/hc-sc\/2005\/13453a-eng.php. Last accessed 1 April 2014."},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.41.1.815"}],"container-title":["Diabetic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdme.12559","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdme.12559","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dme.12559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T07:42:55Z","timestamp":1696318975000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dme.12559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,15]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.1111\/dme.12559"],"URL":"https:\/\/doi.org\/10.1111\/dme.12559","archive":["Portico"],"relation":{},"ISSN":["0742-3071","1464-5491"],"issn-type":[{"value":"0742-3071","type":"print"},{"value":"1464-5491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,15]]},"assertion":[{"value":"2014-01-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-07-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-09-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}